prof. David Creytens
- ORCID iD
-
0000-0002-6064-1673
Show
Sort by
-
- Conference Paper
- C3
- open access
What's new in the 6th edition of the WHO classification for soft tissue tumors-2026?
-
- Miscellaneous
- open access
A CRISPR-based Xenopus tropicalis model for retroperitoneal liposarcoma with genetic control over the dedifferentiation process
-
FOS and FOSB immunohistochemistry and molecular testing reveal novel patterns in proliferative fasciitis and myositis, FOSB rearrangement in proliferative funiculitis, and FOSL1::RELA fusion in pediatric proliferative fasciitis
-
Heterologous rhabdomyoblastic differentiation in dedifferentiated liposarcoma is significantly associated with loss of H3K27 trimethylation
-
- Conference Paper
- C3
- open access
Your sclerosing epithelioid fibrosarcoma refuses to stain for MUC4? Check for the YAP1-KMT2A fusion!
-
- Conference Paper
- C3
- open access
Peripheral neuroblastic tumors-neuroblastoma and pediatric sarcomas : pathology and molecular biology
-
A morphomolecular study of 175 'USP6‐associated neoplasms’ : the USP6 fusion partner strongly depends on morphology and location
-
- Conference Paper
- C3
- open access
Role of the pathologist in diagnosis, prognostication and therapy of soft tissue and bone tumors
-
- Conference Paper
- C3
- open access
Introduction soft tissue tumor course
-
- Conference Paper
- C3
- open access
Soft tissue tumors : what's new in WHO 2026?